LabViews Newsletter October 2008
Biomarkers Europe
Nov. 10 - 11, 2008
InterContinental Wien
Vienna, Austria
DIA 3rd Annual Cardiac Safety Conference
Dec. 4 - 5, 2008
Hotel Hilton
Barcelona, Spain
CBI 3rd Annual Cardiac Safety Assessment Summit
Jan. 12 - 12, 2009
Sheraton Premiere
Vienna, VA
IIR 7th Annual Partnering with Central Labs, EDC and Imaging Labs
Jan. 26 - 28, 2009
Red Rock Resort
Las Vegas, NV
Biomarker Assay Development
Jan. 26 - 28, 2009
Westin San Diego
San Diego, CA
CBI 6th Annual Medical Imaging for Clinical Trials
Feb. 26 - 27, 2009
Washington, DC
Contact Us
Click here to contact Marissa Shapiro, assistant editor.
Click here to learn about direct mail opportunities.
Click here to learn about reprints of Applied Clinical Trials.
ADVERTISMENT
i3
i3 is one of the world’s leading providers of specialized pharmaceutical services, delivering integrated scientific strategies and solutions throughout the product lifecycle. At any point from development to market, anywhere you need to be, we deliver specialization and scientific depth for your most intricate challenges. Look to us to see all the possibilities.
Learn how Cardiac Safety strategies can protect drug research program. Web-Seminar: “Leveraging a Multiphase QT Strategy to Expedite Development and Reduce Investment Risk” on Wednesday, November 5th, 2008, from 11:00am - 12:30pm EST.
For 25 years, IBT Laboratories has provided the broadest range of allergy and immunological tests available from a single provider to complement pharmaceutical product development.
EXPeRT® ePRO – Simplified. Delivered. Guaranteed. Trust your patient reported outcomes with eRT, an industry-leading clinical technology provider.
You are subscribed to apct_enews_labviews as [email protected] To unsubscribe from this list click here.To ensure delivery to your Inbox, please add [email protected] to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
